Mail & Guardian
Mail & Guardian
antiretroviral therapylatest news & developments
UNAids executive director Winnie Byanyima. Image: UNAids on X

Decriminalization – a prerequisite to ending Aids and TB

The same structural failures that sustain the HIV epidemic also sustain tuberculosis

After being diagnosed with HIV at 33, retired Constitutional Court justice Edwin Cameron never thought he’d make it to 40. He’s now 73 and part of a generation that is growing older thanks to antiretrovirals and, he says, the activism that made sure it was available in South Africa. Photo: Stefan Els
Video

HIV made him expect to die at 40. At 73, Edwin Cameron asks: Who’s planning for our ageing survivors?

At 33, the retired Constitutional Court justice thought he had, maybe, seven years left. His story traces the arc from certain death because of Aids to a chronic, manageable…

African health systems have long been undermined by debt and political neglect.

The cost of neglect: Debt’s toll on African health systems

The US withdrawal will reveal the underlying truth: African health systems have long been undermined by debt and political neglect.

South African scientists have released the findings of the first HIV cure trial in Africa with promising results showing viral suppression in 20% of women who stopped taking antiretroviral therapy (ART) after 18 months

SA scientists release promising HIV cure trial results

The study found 20% of women who took a drug intervention that included antibodies remained virally suppressed without antiretroviral therapy after 18 months.

Members of several organisations, NGOs and growers clubs protest as part of the Cannabis Mass Action Gatherings at the Union Building on September 17, 2022 in Pretoria, South Africa. (Photo by Alet Pretorius/Gallo Images via Getty Images)

Cannabis legalisation in Africa: Economic opportunities versus public health risks

Interest in the economic benefits of a cannabis industry far outweigh that of research into issues such as cannabis use disorder

In South Africa, lack of adherence to HIV treatment remains a problem.

HIV responses succeed when we let communities lead

The Nomakhayas of Nqileni in the Eastern Cape give us a case study to replicate This content is restricted to registered users and subscribers. Get Your Free Account The Mail &…

People languish behind bars for years in countries like eSwatini and Malawi before their cases come to court.

A new lease of life for Zimbabwe’s HIV-positive prisoners

Peer support has been pivotal to inmates taking responsibility for their health

Dolutegravir was initially dubbed a wonder drug but a small possible risk of birth defects stalled a global rollout. South Africa has put strict monitoring in place to catch any potential defects early.

Risks & benefits: new HIV drug combo could change the course of SA’s epidemic

South Africa’s next chapter in HIV treatment holds amazing promise, but unlocking it rests on having the right kind of discussions with women